Sanofi India has announced a final dividend of 480% for the financial year ended December 31, 2025, according to an exchange filing. The company’s board of directors approved the recommendation at its meeting held on February 25, 2026.
The declared dividend of 480% translates to Rs 48 per equity share with a face value of Rs 10. The payout has been proposed as the final dividend for FY2025.
The company has fixed April 22, 2026, as both the record date and the ex-dividend date. Shareholders whose names appear in the company’s records as of this date will be eligible to receive the dividend. Investors are required to hold the shares prior to this date to qualify for the payout.
Sanofi India has maintained a consistent dividend distribution record. In 2025, the company paid dividends twice, including Rs 75 per share in November and Rs 117 per share in April. In 2024, it also issued two dividends, amounting to Rs 117 per share in May and Rs 50 per share in March.
Sanofi India is a research-based pharmaceutical company established in 1956 and operates as the Indian arm of France-based multinational Sanofi. The company is engaged in multiple therapeutic segments, including diabetes, cardiology, thrombosis, central nervous system, and vaccines.
The company has a manufacturing presence in India, with operations notably based in Goa. Its product portfolio includes Lantus, Combiflam, and Allegra, which have established demand in the market.
